4.6 Review

Evolution of Foamy Viruses: The Most Ancient of All Retroviruses

Journal

VIRUSES-BASEL
Volume 5, Issue 10, Pages 2349-2374

Publisher

MDPI
DOI: 10.3390/v5102349

Keywords

foamy viruses; retroviruses; hepadnaviruses; evolution; genetic conservation; recombination

Categories

Ask authors/readers for more resources

Recent evidence indicates that foamy viruses (FVs) are the oldest retroviruses (RVs) that we know and coevolved with their hosts for several hundred million years. This coevolution may have contributed to the non-pathogenicity of FVs, an important factor in development of foamy viral vectors in gene therapy. However, various questions on the molecular evolution of FVs remain still unanswered. The analysis of the spectrum of animal species infected by exogenous FVs or harboring endogenous FV elements in their genome is pivotal. Furthermore, animal studies might reveal important issues, such as the identification of the FV in vivo target cells, which than require a detailed characterization, to resolve the molecular basis of the accuracy with which FVs copy their genome. The issues of the extent of FV viremia and of the nature of the virion genome (RNA vs. DNA) also need to be experimentally addressed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Microbiology

The SARS-CoV-2 RNA-protein interactome in infected human cells

Nora Schmidt, Caleb A. Lareau, Hasmik Keshishian, Sabina Ganskih, Cornelius Schneider, Thomas Hennig, Randy Melanson, Simone Werner, Yuanjie Wei, Matthias Zimmer, Jens Ade, Luisa Kirschner, Sebastian Zielinski, Lars Doelken, Eric S. Lander, Neva Caliskan, Utz Fischer, Joerg Vogel, Steven A. Carr, Jochen Bodem, Mathias Munschauer

Summary: Characterizing the interactions between SARS-CoV-2 viral RNAs and host cell proteins during infection can enhance our understanding of viral RNA functions and the host innate immune response. Identification of specific host proteins that restrict viral replication and exploring defense strategies will aid in the development of targeted therapeutics against SARS-CoV-2.

NATURE MICROBIOLOGY (2021)

Article Chemistry, Multidisciplinary

Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors

Julian Breidenbach, Carina Lemke, Thanigaimalai Pillaiyar, Laura Schaekel, Ghazl Al Hamwi, Miriam Diett, Robin Gedschold, Nina Geiger, Vittoria Lopez, Salahuddin Mirza, Vigneshwaran Namasivayam, Anke C. Schiedel, Katharina Sylvester, Dominik Thimm, Christin Vielmuth, Lan Phuong Vu, Maria Zyulina, Jochen Bodem, Michael Guetschow, Christa E. Mueller

Summary: Two classes of protease inhibitors, azanitriles and pyridyl esters, were identified and optimized for potential use against COVID-19. Tailored peptides with unique azanitrile warheads showed promising results in inhibiting M-pro and cathepsin L. Through a focused approach, two irreversible inhibitors, azanitrile 8 and pyridyl ester 17, have been discovered as potential drug candidates for further development.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Multidisciplinary Sciences

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue

Melissa Zimniak, Luisa Kirschner, Helen Hilpert, Nina Geiger, Olga Danov, Heike Oberwinkler, Maria Steinke, Katherina Sewald, Juergen Seibel, Jochen Bodem

Summary: Research has found that Fluoxetine can effectively inhibit SARS-CoV-2 infection and show activity in human lung tissue. Both stereoisomers of Fluoxetine exhibit similar activity against the virus, with the R-form possibly being specifically used for SARS-CoV-2 treatment.

SCIENTIFIC REPORTS (2021)

Article Microbiology

Facile Synthesis and In Vitro Activity of N-Substituted 1,2-Benzisothiazol-3(2H)-ones against Dengue Virus NS2BNS3 Protease

Farwa Batool, Muhammad Saeed, Hafiza Nosheen Saleem, Luisa Kirschner, Jochen Bodem

Summary: This study synthesized several new N-substituted 1,2-benzisothiazol-3(2H)-ones (BITs) through a simplified synthetic route and tested their inhibitory activity against dengue virus protease. The results indicate the potential of two BITs for developing new anti-dengue therapeutics.

PATHOGENS (2021)

Article Immunology

SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro

Fengming Liu, Kun Han, Robert Blair, Kornelia Kenst, Zhongnan Qin, Berin Upcin, Philipp Woersdoerfer, Cecily C. Midkiff, Joseph Mudd, Elizaveta Belyaeva, Nicholas S. Milligan, Tyler D. Rorison, Nicole Wagner, Jochen Bodem, Lars Doelken, Bertal H. Aktas, Richard S. Vander Heide, Xiao-Ming Yin, Jay K. Kolls, Chad J. Roy, Jay Rappaport, Sueleyman Erguen, Xuebin Qin

Summary: This study found that SARS-CoV-2 may directly infect mature vascular endothelial cells in vivo and ex vivo, potentially contributing to cardiovascular complications in SARS-CoV-2 infection, including multiple organ failure.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Cell & Tissue Engineering

The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS route for SARS-CoV-2

Susanne Krasemann, Undine Haferkamp, Susanne Pfefferle, Marcel S. Woo, Fabian Heinrich, Michaela Schweizer, Antje Appelt-Menzel, Alevtina Cubukova, Janica Barenberg, Jennifer Leu, Kristin Hartmann, Edda Thies, Jessica Lisa Littau, Diego Sepulveda-Falla, Liang Zhang, Kathy Ton, Yan Liang, Jakob Matschke, Franz Ricklefs, Thomas Sauvigny, Jan Sperhake, Antonia Fitzek, Anna Gerhartl, Andreas Brachner, Nina Geiger, Eva-Maria Koenig, Jochen Bodem, Soren Franzenburg, Andre Franke, Stefan Moese, Franz-Josef Mueller, Gerd Geisslinger, Carsten Claussen, Aimo Kannt, Andrea Zaliani, Philip Gribbon, Benjamin Ondruschka, Winfried Neuhaus, Manuel A. Friese, Markus Glatzel, Ole Pless

Summary: Neurological complications are common in COVID-19. This study reveals that SARS-CoV-2 can enter the brain through the blood-brain barrier and cause increased interferon signaling. In vitro experiments show that SARS-CoV-2 can infect BCECs and replicate, with the virus being transported across the barrier. This process can be inhibited by specific antibodies or inhibitors.

STEM CELL REPORTS (2022)

Article Immunology

Flt3L, LIF, and IL-10 combination promotes the selective in vitro development of ESAMlow cDC2B from murine bone marrow

Laura Cyran, Julia Serfling, Luisa Kirschner, Hartmann Raifer, Michael Lohoff, Heike M. Hermanns, Andreas Kerstan, Jochen Bodem, Manfred B. Lutz

Summary: FL10 selectively promotes the development and survival of cDC2 subset in bone marrow cells, which exhibit unique characteristics in the expression of transcription factors and immune response compared to other cells.

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Article Biotechnology & Applied Microbiology

Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2

Maik Friedrich, Gabriele Pfeifer, Stefanie Binder, Achim Aigner, Philippe Vollmer Barbosa, Gustavo R. Makert, Jasmin Fertey, Sebastian Ulbert, Jochen Bodem, Eva-Maria Koenig, Nina Geiger, Axel Schambach, Erik Schilling, Tilo Buschmann, Sunna Hauschildt, Ulrike Koehl, Katherina Sewald

Summary: In 2019, the SARS-CoV-2 outbreak caused a global pandemic. Besides vaccines, there is a need for novel treatment options. The use of siRNA targeting ACE2 and the SARS-CoV-2 RNA genome is an effective strategy to prevent viral entry into host cells or interfere with viral replication.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

Article Cell Biology

The Acid Ceramidase Is a SARS-CoV-2 Host Factor

Nina Geiger, Louise Kersting, Jan Schlegel, Linda Stelz, Sofie Faehr, Viktoria Diesendorf, Valeria Roll, Marie Sostmann, Eva-Maria Koenig, Sebastian Reinhard, Daniela Brenner, Sibylle Schneider-Schaulies, Markus Sauer, Jurgen Seibel, Jochen Bodem

Summary: The study demonstrates that fluoxetine and its derivative AKS466 can interfere with the replication of SARS-CoV-2 by inhibiting acid ceramidase activity. The findings suggest that acid ceramidase may serve as a host factor for SARS-CoV-2.

CELLS (2022)

Article Immunology

Acetylsalicylic Acid and Salicylic Acid Inhibit SARS-CoV-2 Replication in Precision-Cut Lung Slices

Nina Geiger, Eva-Maria Koenig, Heike Oberwinkler, Valeria Roll, Viktoria Diesendorf, Sofie Faehr, Helena Obernolte, Katherina Sewald, Sabine Wronski, Maria Steinke, Jochen Bodem

Summary: The study found that aspirin and its metabolite salicylic acid can inhibit the replication of SARS-CoV-2 virus in cells. Although these compounds do not interfere with viral entry, they can inhibit post-entry pathways, thereby reducing the expression of viral RNA.

VACCINES (2022)

Article Biochemistry & Molecular Biology

Azido-Ceramides, a Tool to Analyse SARS-CoV-2 Replication and Inhibition-SARS-CoV-2 Is Inhibited by Ceramides

Daniela Brenner, Nina Geiger, Jan Schlegel, Viktoria Diesendorf, Louise Kersting, Julian Fink, Linda Stelz, Sibylle Schneider-Schaulies, Markus Sauer, Jochen Bodem, Juergen Seibel

Summary: Recently, the effectiveness of C6-ceramides in suppressing viral replication by trapping the virus in lysosomes has been demonstrated. In this study, a synthetic ceramide derivative called AKS461 was evaluated for its antiviral activity against SARS-CoV-2. The results showed that AKS461 accumulated in lysosomes and efficiently inhibited SARS-CoV-2 replication in different cell types. This study highlights the importance of lysosomes as the central organelle for C6-ceramides to inhibit viral replication and provides a tool for studying ceramide-associated cellular and viral pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9

Nora Schmidt, Sabina Ganskih, Yuanjie Wei, Alexander Gabel, Sebastian Zielinski, Hasmik Keshishian, Caleb A. Lareau, Liv Zimmermann, Jana Makroczyova, Cadence Pearce, Karsten Krey, Thomas Hennig, Sebastian Stegmaier, Lambert Moyon, Marc Horlacher, Simone Werner, Jens Aydin, Marco Olguin-Nava, Ramya Potabattula, Anuja Kibe, Lars Doelken, Redmond P. Smyth, Neva Caliskan, Annalisa Marsico, Christine Krempl, Jochen Bodem, Andreas Pichlmair, Steven A. Carr, Petr Chlanda, Florian Erhard, Mathias Munschauer

Summary: Regulation of viral RNA biogenesis is crucial for SARS-CoV-2 infection. The host protein SND1 is identified to bind negatively-sense viral RNA and is essential for SARS-CoV-2 RNA synthesis. The viral protein NSP9 is covalently linked to the ends of viral RNA during infection and interacts with SND1 to initiate viral RNA synthesis.
Article Immunology

Enolase 1 of Candida albicans binds human CD4(+) T cells and modulates naive and memory responses

Muhammad Daud, Prasad Dasari, Marion Adelfinger, Daniela Langenhorst, Jasmin Lother, Dragana Slavkovic-Lukic, Carsten Berges, Michaela Kruhm, Annette Galler, Cathrin Schleussner, Christian H. Luther, Karl Alberter, Anton Althammer, Haroon Shaikh, Niklas Pallmann, Jochen Bodem, Mohammed El-Mowafy, Andreas Beilhack, Marcus Dittrich, Max S. Topp, Peter F. Zipfel, Niklas Beyersdorf

Summary: To gain a better understanding of life-threatening fungal infections caused by Candida albicans, our study conducted in silico screening to identify protein interactions between the fungus and the host. We discovered that the human CD4 binds to the C. albicans protein enolase 1 (Eno1), which affects the immune response and cytokine secretion. This interaction modulates CD4(+) T-cell responses, favoring the fungus.

EUROPEAN JOURNAL OF IMMUNOLOGY (2023)

Article Biochemistry & Molecular Biology

Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors

Nina Geiger, Viktoria Diesendorf, Valeria Roll, Eva-Maria Koenig, Helena Obernolte, Katherina Sewald, Julian Breidenbach, Thanigaimalai Pillaiyar, Michael Guetschow, Christa E. Mueller, Jochen Bodem

Summary: Recently, we investigated novel pyridyl indole esters and peptidomimetics as potent inhibitors of SARS-CoV-2 main protease. We analyzed the impact of these compounds on viral replication and found that their effectiveness varied in different cell lines. In Huh-7 cells, the protease inhibitors suppressed viral replication by up to 5 orders of magnitude, while in Calu-3 cells, suppression by 2 orders of magnitude was achieved. Three pyridin-3-yl indole-carboxylates showed antiviral activity in all cell lines and also in human precision-cut lung slices.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Integrative & Complementary Medicine

A defined anthocyanin mixture sourced from bilberry and black currant inhibits Measles virus and various herpesviruses

Rinu Sivarajan, Heike Oberwinkler, Valeria Roll, Eva-Maria Koenig, Maria Steinke, Jochen Bodem

Summary: This study found that compounds in black currant and bilberry extracts have inhibitory effects on measles virus and herpes simplex virus. Furthermore, these compounds exhibit synergistic effects with aciclovir and also inhibit the replication of human herpesvirus 8.

BMC COMPLEMENTARY MEDICINE AND THERAPIES (2022)

No Data Available